Although palmitic acid and stearic acid are both long-chain saturated fatty acids, their effects on blood lipids are not equivalent. Existing research indicates that palmitic acid has a stronger cholesterol-raising effect, while stearic acid behaves more moderately in the body.

The picture becomes less settled beyond cholesterol. Evidence remains insufficient to draw firm conclusions about how the two fatty acids differ in their effects on blood glucose regulation, insulin homeostasis, and systemic inflammation, all of which are relevant to cardiovascular and metabolic risk.

The distribution of fatty acids on the triglyceride (TAG) molecule, at the sn-1, sn-2, and sn-3 positions, is a key determinant of both physical properties and metabolic fate. In food processing, interesterification uses chemical or enzymatic methods to rearrange fatty acids on the TAG backbone, allowing manufacturers to adjust melting points and texture.

The technique can produce solid fats suited to baking or margarine without the trans fatty acids generated by partial hydrogenation. In palm oil, for example, a substantial share of saturated fatty acids is normally located at the sn-1 and sn-3 positions; interesterification can move them to the sn-2 position and thereby raise the oil's melting point.

Research indicates that fatty acids located at the sn-2 position are more readily retained when dietary fats enter chylomicrons. That suggests interesterification, by changing the molecular structure of a fat, may also change its metabolic route in the body.

Because fats rich in palmitic and stearic acids are widely used in industrial processing, researchers are working to systematically assess how these structurally altered fats affect long-term and postprandial cardiometabolic markers. The question is not only how much saturated fat is consumed, but how it is arranged and delivered to the body.